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Histologic grading: A, B, C or 1, 2, 3?
To the Editor:
Mr Lee and colleagues from Dr Shennib's group are to be
congratulated for an interesting and provocative study (J
Thorac Cardiovasc Surg 1998;115:822-7) that supports their
hypothesis that bronchiolitis obliterans is not related just to
chronic rejectiOn in lung allografts. Using activated charcoal
as an airway irritant the authors demonstrated that either an
irritant alone or reduced immunm,uppression after transplan-
tation resulted III mild bronchiolitis. but the combination of
airway irritant and reduced immunosuppression produced
more impressive histologic findings consistent with oblitera-
tive bronchiolitis.
However. I take issue with the calculation of mean grades
of airway injury using a grading system that arbitrarily
assigns numbers to histologic patterns of injury. If the histo-
logic categories were labeled A, B. C. and D instead of I, 2,
3, and 4, what would be the mean of 2 A's and 3 CS'1 It would
be statistically appropriate to compare the groups by looking
at the distribution of scores Within each group, rather than
calculating a mean from data that are not arithmetic.
Although this is common practice with histologic grades. it is
mathematically inappropriate. Unfortunately, the need for
nonparametric analysis translates IlltO a requirement for a
much larger number of animals to establish statistical signif-
icance to the observation. This criticism is not meant to
detract from the elegance of the experiment but only to raise
the point that not all observations need to be "statistically sig-
mficant" before they are relevant. Perhaps the authors could
share the distribution of scores, rather than the mean scores.
Thomas M. Egan, MD
Professor
Assuciate Division Chieffor General ThoraCIC Surgery
Department of Surgel)'
University ofNorth Carulina at Chapel Hill
108 Burnett-Womack Building
CB 7065
Chapel Hill, NC 27599-7065
12/8/94225
Reply to the Editor:
The comment made by Dr Thomas Egan is well taken.
Grading the severity of airway injury by nonparametnc
analysis requires an extensive number of animals, which we
could not determine before the experiment When data were
reviewed by classification A. B. C. and D Illstead of I. 2. 3,
and 4, we found there were 5 A's and 3 B's in group I (trans-
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plantation alone). 4 Cs and 6 D's in group II (transplantation
plus charcoal), and 2 A's, 7 B's. and 1 C in group III (char-
coal alone). As such, the data stand to confirm that the com-
bination of transplantation and charcoal transtracheal injec-
tion result in more pronounced injury to the airway.
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Multiple primary lung carcinomas
To the Editor:
The report by Okada and colleagues! highlights the treat-
ment options and survival statistics that are appropriate for
patients with multiple primary lung carcinomas (MPLCs).
but we think some further points need to be discussed.
In a recent article by Antakli and colleagues." a set of cri-
tena modified from Martini and Melamed' has been applied
to differentiate MPLCs and recurrence of satellite nodules. In
addition to those mentioned by Okada and associates, associ-
ated premalignant lesions and different DNA ploidy have
been presented as the 2 other criteria in the case of identical
histologic type." When Martini and Melamed's criteria were
not conclusive, they advocated DNA ploidy to provide a def-
inite answer to this dilemma. However. Okada and colleagues
have not suggested using the ploidy issue for patients with
MPLCs.
We performed left pneumonectomy for a 60-year-old man
who was operated on for squamous cell carcinoma of the lung
(T2 Nl MO, grade III). One year after the operation, a nodule
with a 2.5-cm diameter located in the right upper lobe was
detected by both chest roentgenography and chest computed
tomography. Segmentectomy was performed, and the histo-
logic type of this tumor was the same as that of the first one
(T2 NO MO, grade III). We conSidered this tumor to be a sec-
ond primary lung cancer. because the tumor was anatomical-
ly separate and did not have any systemic metastases or medi-
astinal spread. On the other hand, although the number of
criteria that had to be met in the case of identical histologic
type was sufficient we used the ploidy issue in our patient.
Even though the histologic features were the same in all of
the lesions, the DNA ploidy signatures differed.
Although lung-saving procedures for a primary lesion are
advocated in the article.! the risk of having MPLCs after
pneumonectomy is significantly lower than after lobectomies
or miniresections.2
Another point is the striking prevalence of smoking among
the patients with MPLCs and the preventive effect of cessa-
tion that has been demonstrated by many authors.",4 Do
Okada and associates have any information about the preva-
lence of smoking among their patients?
From the historical point of view. we would like to know
